|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004238,
umls-concept:C0030705,
umls-concept:C0032143,
umls-concept:C0034975,
umls-concept:C0038454,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0332281,
umls-concept:C0348016,
umls-concept:C0449820,
umls-concept:C1274040
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2011-6-13
|
|
pubmed:abstractText |
The aim of this study was to examine whether CHADS(2) score is associated with clinical outcomes following recombinant tissue type plasminogen activator (rt-PA) therapy in stroke patients with atrial fibrillation (AF).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1878-5883
|
|
pubmed:author |
pubmed-author:FuruiEisukeE,
pubmed-author:HasegawaYasuhiroY,
pubmed-author:KarioKazuomiK,
pubmed-author:KimuraKazumiK,
pubmed-author:KogaMasatoshiM,
pubmed-author:MaedaKoichiroK,
pubmed-author:MinematsuKazuoK,
pubmed-author:NaganumaMasakiM,
pubmed-author:NakagawaraJyojiJ,
pubmed-author:NezuTomohisaT,
pubmed-author:OkadaYasushiY,
pubmed-author:OkudaSatoshiS,
pubmed-author:ShibazakiKensakuK,
pubmed-author:ShiokawaYoshiakiY,
pubmed-author:ToyodaKazunoriK,
pubmed-author:YamagamiHiroshiH
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
306
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
49-53
|
|
pubmed:meshHeading |
pubmed-meshheading:21492878-Age Factors,
pubmed-meshheading:21492878-Aged,
pubmed-meshheading:21492878-Aged, 80 and over,
pubmed-meshheading:21492878-Atrial Fibrillation,
pubmed-meshheading:21492878-Female,
pubmed-meshheading:21492878-Fibrinolytic Agents,
pubmed-meshheading:21492878-Humans,
pubmed-meshheading:21492878-Injections, Intravenous,
pubmed-meshheading:21492878-Male,
pubmed-meshheading:21492878-Severity of Illness Index,
pubmed-meshheading:21492878-Stroke,
pubmed-meshheading:21492878-Tissue Plasminogen Activator,
pubmed-meshheading:21492878-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
|
|
pubmed:affiliation |
Division of Stroke Care Unit, National Cerebral and Cardiovascular Center, Suita, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
